BioRestorative Therapies, Inc. (OTCMKTS:BRTX – Get Rating) major shareholder Dale Broadrick acquired 3,000 shares of BioRestorative Therapies stock in a transaction on Monday, June 6th. The shares were purchased at an average cost of $4.93 per share, with a total value of $14,790.00. Following the completion of the acquisition, the insider now owns 282,673 shares of the company’s stock, valued at approximately $1,393,577.89. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Major shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.

Dale Broadrick also recently made the following trade(s):

• On Thursday, June 2nd, Dale Broadrick purchased 1,000 shares of BioRestorative Therapies stock. The stock was bought at an average cost of $4.69 per share, with a total value of $4,690.00.
• On Thursday, May 26th, Dale Broadrick acquired 4,950 shares of BioRestorative Therapies stock. The shares were bought at an average cost of $3.51 per share, for a total transaction of $17,374.50.
• On Tuesday, April 5th, Dale Broadrick bought 46,000 shares of BioRestorative Therapies stock. The shares were acquired at an average price of $5.71 per share, with a total value of $262,660.00.
• On Thursday, March 31st, Dale Broadrick bought 10,700 shares of BioRestorative Therapies stock. The shares were bought at an average price of $4.72 per share, with a total value of $50,504.00.
• On Tuesday, March 29th, Dale Broadrick bought 5,000 shares of BioRestorative Therapies stock. The shares were bought at an average price of $5.12 per share, with a total value of $25,600.00.
• On Monday, March 21st, Dale Broadrick acquired 10,000 shares of BioRestorative Therapies stock. The shares were acquired at an average cost of $4.35 per share, with a total value of $43,500.00.
• On Wednesday, March 9th, Dale Broadrick acquired 11,875 shares of BioRestorative Therapies stock. The shares were acquired at an average cost of $4.00 per share, with a total value of $47,500.00.

Shares of BRTX stock traded down $0.05 during mid-day trading on Tuesday, reaching $4.77. 12,498 shares of the company’s stock traded hands, compared to its average volume of 12,783. BioRestorative Therapies, Inc. has a 12 month low of $3.28 and a 12 month high of $39.20. The firm has a 50 day moving average price of $4.48 and a two-hundred day moving average price of $4.54.

An institutional investor recently bought a new position in BioRestorative Therapies stock. Cambridge Investment Research Advisors Inc. acquired a new stake in shares of BioRestorative Therapies, Inc. (OTCMKTS:BRTX – Get Rating) in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 23,001 shares of the company’s stock, valued at approximately $120,000. Cambridge Investment Research Advisors Inc. owned 0.63% of BioRestorative Therapies at the end of the most recent reporting period. Institutional investors and hedge funds own 16.52% of the company’s stock.

BioRestorative Therapies Company Profile (Get Rating)

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company’s two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.

Featured Stories

Receive News & Ratings for BioRestorative Therapies Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for BioRestorative Therapies and related companies with MarketBeat.com’s FREE daily email newsletter.